RenovoRx: director Marton Laurence received 55,924 shares

What happened Marton Laurence, director, received 55,924 derivative shares as a grant on Oct 1, 2026, at $0.00 per share for a total of $0.00. The Form 4 lists the transaction as a grant/award (code A) of derivative securities.

Key details

• Transaction date and price: Oct 1, 2026; $0.00 per share.
• Transaction type: grant/award (derivative, code A).
• Shares owned after the transaction: not reported in the filing.
• Footnote F1: the shares subject to the option vest in 12 equal monthly installments beginning on Nov 1, 2026.
• Filing date and timeliness: Form 4 filed Oct 2, 2026, reporting the Oct 1, 2026 transaction.

Why it may matter

• The filing shows an award of derivative securities that vest over time per footnote F1.
• A filing does not show why the insider traded or why the company acted.